Boyer David W. bought NBIX
September 11, 2026 · Form 4 insider transaction
Boyer David W. bought 3,587 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,587
Price
$0.00
Total value
N/A
InsiderBoyer David W.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after11,484
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026.; Includes an aggregate of 98 shares purchased on August 31, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.